CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- POS AM Other Post-effective Amendment for Registration Statement
- POS EX Other Post-effective Amendment
- 424B3 Offering Prospectus
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 4 Open-market buy President & CEO bought 5,000 shares
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 3 of 26 · 511 filings